Bright Minds Biosciences Inc (DRUG) Stock Price, Quote & News

Company Profile

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develo...

Industry: Biotechnology

Sector: Healthcare

Phone: 647 865 8622

Website: brightmindsbio.com

Address:

19 Vestry Street, New York, United States

Alchemisttt Jun. 4 at 4:19 PM

$VERU this is gonna $DRUG

0 · Reply

Trick2MoneyisHavingSum Jun. 3 at 12:27 PM

$HUBC when you see it squeezing JUMP in FOLKS $DRUG $NUKK

0 · Reply

Source206 Jun. 2 at 5:41 PM

$DRUG I'm buying at these prices

0 · Reply

Benbobaggins Jun. 1 at 11:25 AM

$SOAR anyone remember when $DRUG flew. Pretty sure $SOAR can soar through🐋🐳🐂🚀

0 · Reply

Trick2MoneyisHavingSum May. 28 at 11:00 AM

$ATPC fireworks after $6.72 $DRUG $WHLR

0 · Reply

Paraboljoker May. 27 at 2:06 PM

$ISPC has that broken look above $4.30 key break , who remembers $DRUG ??

0 · Reply

Paraboljoker May. 27 at 12:02 PM

$ISPC has that broken look above $4.10, who remembers $DRUG?

0 · Reply

TraderBuckNKY May. 27 at 11:42 AM

$VRAX I didn't see it as a speech. Mr. Foster is not a gifted speaker (thank goodness)...I saw and heard a visionary with incredible goals laid out and a step-by-step plan to achieve all of them. The slide show was well presented in and of itself answering all my questions. Foster has done his research and aligned the right partners and is onto something very big...I'll be doubling my position...remember $DRUG...? go back 5 years and see, read and watch what happened there...$50.00 p/s is possible....

1 · Reply

LeiteCondensado May. 27 at 10:20 AM

$SNGX - Imagine if this did a $DRUG type of move?

0 · Reply

simplifocused May. 23 at 1:15 PM

$ARTL this is the next $DRUG NFA

0 · Reply

Bright Minds Biosciences Transcript: Jefferies Global Healthcare Conference 2026

Tue, 26 May 2026 19:18:00 -0400 - 9 days ago

Bright Minds Biosciences to Present at Jefferies Global Healthcare Conference

2026-05-21T21:31:11.000Z - 14 days ago

Why a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipeline

2026-05-20T10:45:58.000Z - 15 days ago

Bright Minds price target raised to $220 from $190 at Piper Sandler

DRUG

May 19, 2026, 4:00 PM EDT - 16 days ago

Bright Minds Biosciences Registration statement: Q2 2026

May 19, 2026, 4:00 PM EDT - 16 days ago

Bright Minds Biosciences Registration statement: Q2 2026

2026-04-13T13:55:38.000Z - 7 weeks ago

DRUG Initiates Coverage On Bright Minds Biosciences -- Price Target Announced

2026-04-12T23:20:16.000Z - 7 weeks ago

Bright Minds initiated with a Buy at Jefferies

2026-03-04T20:00:37.000Z - 3 months ago

Bright Minds Biosciences Inc at TD Cowen Healthcare Conference Transcript

Mar 4, 2026, 9:10 AM EST - 3 months ago

Bright Minds Biosciences Transcript: TD Cowen 46th Annual Health Care Conference

2026-03-04T13:39:47.000Z - 3 months ago

Bright Minds price target raised to $145 from $115 at H.C. Wainwright

Wed, 25 Feb 2026 16:30:00 -0500 - 3 months ago

Bright Minds Biosciences to Present at Upcoming Conferences

2026-02-17T11:31:20.000Z - 3 months ago

BTIG Maintains Buy Rating for Bright Minds Biosciences (DRUG) with $147 Target | DRUG Stock News

2026-02-13T14:21:13.000Z - 3 months ago

Bright Minds price target lowered to $126 from $142 at Baird

Feb 11, 2026, 6:00 PM EST - 4 months ago

Bright Minds Biosciences Registration statement: Q1 2026

Feb 11, 2026, 6:00 PM EST - 4 months ago

Bright Minds Biosciences Registration statement: Q1 2026

Fri, 09 Jan 2026 11:56:00 -0500 - 5 months ago

Bright Minds Biosciences Announces Closing of US$175 Million Public Offering

2026-01-08T07:57:10.000Z - 5 months ago

Bright Minds Biosciences (DRUG) Prices $175M Public Offering

Wed, 07 Jan 2026 21:33:00 -0500 - 5 months ago

Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock

2026-01-07T13:05:22.000Z - 5 months ago

Bright Minds Biosciences, Praxis Precision Medicines And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

2026-01-07T13:00:57.000Z - 5 months ago

Bright Minds price target raised to $142 from $82 at Baird

2026-01-07T11:46:42.000Z - 5 months ago

Bright Minds price target raised to $147 from $72 at BTIG

2026-01-06T21:11:24.000Z - 5 months ago

Bright Minds announces $100M common shares offering

Tue, 06 Jan 2026 16:00:00 -0500 - 5 months ago

Bright Minds Biosciences Announces Launch of US$100 Million Public Offering

2026-01-06T18:31:59.000Z - 5 months ago

BTIG Raises Price Target for Bright Minds Biosciences (DRUG) to $147 | DRUG Stock News

2026-01-06T18:00:09.000Z - 5 months ago

Bright Minds Biosciences Inc BMB-101 Topline data announcement Transcript

Tue, 06 Jan 2026 11:52:33 -0500 - 5 months ago

New Bright Minds Epilepsy Drug Cuts Seizures, Lifts Stock On Tuesday

2026-01-06T15:07:53.000Z - 5 months ago

Microchip Technology, Alumis, Terrestrial Energy, Bright Minds Biosciences And Other Big Stocks Moving Higher On Tuesday

2026-01-06T13:00:04.000Z - 5 months ago

Bright Minds Biosciences (DRUG) Surges on Successful Trial Results

Jan 6, 2026, 8:00 AM EST - 5 months ago

Bright Minds Biosciences Transcript: Study Result

Jan 6, 2026, 8:00 AM EST - 5 months ago

Bright Minds Biosciences Press release: Study Result

Jan 6, 2026, 8:00 AM EST - 5 months ago

Bright Minds Biosciences Slides: Study Result

2026-01-06T12:25:21.000Z - 5 months ago

Bright Minds announces results from Phase 2 BREAKTHROUGH trial of BMB-101

Tue, 06 Jan 2026 07:16:00 -0500 - 5 months ago

Bright Minds Biosciences Announces Positive Topline Results from Phase 2 Clinical Trial of BMB-101 in Patients with Absence Seizures and Developmental and Encephalopathic Epilepsies (DEE)

2026-01-06T09:04:44.000Z - 5 months ago

Bright Minds To Unveil Topline Results For BMB-101 Phase 2 Trial In Absence Seizures And DEE

Mon, 05 Jan 2026 16:30:00 -0500 - 5 months ago

Bright Minds to Announce Topline Results for BMB-101 Phase 2 Trial in Absence Seizures and Developmental and Epileptic Encephalopathies on Tuesday, January 6, 2026

Jan 4, 2026, 7:00 AM EST - 5 months ago

Bright Minds Biosciences Slides: Corporate Presentation

2026-01-02T13:30:17.000Z - 5 months ago

Bright Minds Biosciences (DRUG) Maintains Buy Rating with $80 Price Target | DRUG Stock News

2025-12-30T16:00:54.000Z - 5 months ago

Bright Minds Biosciences (DRUG) Sees Stable Analyst Rating Today | DRUG Stock News

Dec 23, 2025, 7:00 AM EST - 5 months ago

Bright Minds Biosciences Registration statement: Q4 2025

Dec 23, 2025, 7:00 AM EST - 5 months ago

Bright Minds Biosciences Registration statement: Q4 2025

Dec 23, 2025, 7:00 AM EST - 5 months ago

Bright Minds Biosciences Annual report: Q4 2025

Nov 25, 2025, 4:30 PM EST - 6 months ago

Bright Minds Biosciences to Present at Piper Sandler 37th Annual Healthcare Conference and 2025 AES Annual Meeting

Mon, 17 Nov 2025 17:29:36 -0500 - 7 months ago

Why Bright Minds Biosciences Stock Topped the Market on Monday

Nov 17, 2025, 6:50 AM EST - 7 months ago

Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Experts in Prader-Willi Syndrome (PWS)

Nov 12, 2025, 9:00 AM EST - 7 months ago

Bright Minds Biosciences Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference

2025-11-07T12:25:38.000Z - 7 months ago

Bright Minds price target raised to $82 from $75 at Baird

Nov 6, 2025, 10:00 AM EST - 7 months ago

Bright Minds Biosciences Transcript: KOL Event

Nov 6, 2025, 10:00 AM EST - 7 months ago

Bright Minds Biosciences Press release: KOL Event

Nov 6, 2025, 6:30 AM EST - 7 months ago

Bright Minds Biosciences Initiates New Prader-Willi Syndrome (PWS) Program; KOL Event Scheduled for November 6TH

Nov 5, 2025, 6:00 PM EST - 7 months ago

Bright Minds Biosciences Slides: Corporate Presentation

2025-09-08T09:55:04.000Z - 9 months ago

Bright Minds initiated with a Buy at BTIG

2025-09-04T12:35:25.000Z - 9 months ago

Bright Minds says BMB-201 outperforms sumatriptan in preclinical model

Aug 26, 2025, 8:00 AM EDT - 10 months ago

Bright Minds Biosciences Registration statement: Registration Filing

Aug 13, 2025, 6:00 PM EDT - 10 months ago

Bright Minds Biosciences Registration statement: Q3 2025

Aug 13, 2025, 6:00 PM EDT - 10 months ago

Bright Minds Biosciences Registration statement: Q3 2025

May 20, 2025, 8:00 AM EDT - 1 year ago

Bright Minds Biosciences Announces Featured Speakers for its Absence Epilepsy Virtual R&D Day on May 20, 2025

May 16, 2025, 4:00 PM EDT - 1 year ago

Bright Minds Biosciences Registration statement: Q2 2025

May 16, 2025, 4:00 PM EDT - 1 year ago

Bright Minds Biosciences Registration statement: Q2 2025

May 13, 2025, 4:00 PM EDT - 1 year ago

Bright Minds Biosciences Press release: Study Update

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Bright Minds Biosciences to Host Virtual R&D Day on May 20, 2025; Program Highlights Include an Overview of Absence Seizures and the BMB-101 Phase 2 Study

Feb 14, 2025, 4:00 PM EST - 1 year ago

Bright Minds Biosciences Registration statement: Q1 2025

Feb 14, 2025, 4:00 PM EST - 1 year ago

Bright Minds Biosciences Registration statement: Q1 2025

Feb 5, 2025, 7:00 AM EST - 1 year ago

Bright Minds Biosciences Registration statement: Registration Filing

Jan 7, 2025, 6:50 AM EST - 1 year ago

Bright Minds Biosciences Appoints Pharmaceutical Leader, Stephen Collins, M.D., Ph.D., as Chief Medical Officer

Dec 30, 2024, 4:00 PM EST - 1 year ago

Bright Minds Biosciences Annual report: Q4 2024

Wed, 13 Nov 2024 12:59:00 -0500 - 1 year ago

Meet the Biotech Stock That Has Generated Nvidia-Like Returns in Less Than a Month

Nov 4, 2024, 2:41 PM EST - 1 year ago

Bright Minds Biosciences Closes US$35 Million Non-Brokered Private Placement

Oct 28, 2024, 8:21 AM EDT - 1 year ago

PESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data Update

NVCT

Oct 21, 2024, 8:30 AM EDT - 1 year ago

Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data

Oct 18, 2024, 6:50 AM EDT - 1 year ago

Bright Minds Biosciences Announces US$35 Million Non-Brokered Private Placement

Oct 16, 2024, 4:00 PM EDT - 1 year ago

Bright Minds Biosciences Press release: Study Update

Oct 16, 2024, 10:45 AM EDT - 1 year ago

Bright Minds Biosciences proprietary compound, BMB-201, 5-HT2C/2A mixed agonist, demonstrated similar efficacy to morphine in preclinical pain models

Oct 16, 2024, 8:46 AM EDT - 1 year ago

Bright Minds Biosciences Stock Surges Almost 1,500%

Oct 16, 2024, 5:57 AM EDT - 1 year ago

Biotech stock tumbles after unexplained 1,446% gain

Oct 15, 2024, 9:09 PM EDT - 1 year ago

Bright Minds is Unaware of Any Material Changes

Oct 3, 2024, 9:00 AM EDT - 1 year ago

Bright Minds Biosciences announces participation in upcoming scientific conferences and partnering events

Sep 19, 2024, 10:00 AM EDT - 1 year ago

Bright Minds Biosciences to Host Investor & Analyst KOL Event on September 25th

Sep 12, 2024, 8:00 AM EDT - 1 year ago

Bright Minds Biosciences Initiates the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy

Aug 14, 2024, 4:00 PM EDT - 1 year ago

Bright Minds Biosciences Registration statement: Q3 2024

Aug 14, 2024, 4:00 PM EDT - 1 year ago

Bright Minds Biosciences Registration statement: Q3 2024

May 15, 2024, 4:00 PM EDT - 2 years ago

Bright Minds Biosciences Registration statement: Q2 2024

May 15, 2024, 4:00 PM EDT - 2 years ago

Bright Minds Biosciences Registration statement: Q2 2024

Feb 12, 2024, 4:00 PM EST - 2 years ago

Bright Minds Biosciences Registration statement: Q1 2024

Feb 12, 2024, 4:00 PM EST - 2 years ago

Bright Minds Biosciences Registration statement: Q1 2024

Aug 8, 2023, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences Announces Positive qEEG (Quantitative Electroencephalogram) Data from its First-in-Human Phase 1 Study of Lead Compound, BMB-101

Jul 20, 2023, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences Announces Positive Topline Data for its First-in-Human Phase 1 Study of Lead Compound, BMB-101

Jul 12, 2023, 10:33 AM EDT - 3 years ago

CSE Bulletin: Consolidation - Bright Minds Biosciences Inc. (DRUG)

Jul 11, 2023, 6:50 AM EDT - 3 years ago

Bright Minds Announces Effective Date of Share Consolidation

Jun 22, 2023, 6:50 AM EDT - 3 years ago

Bright Minds Announces Proposed Share Consolidation

Apr 19, 2023, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences Receives a Favorable Written Opinion from the International Searching Authority for BMB-202

Apr 10, 2023, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences to Present at the 20th International Meeting of the International Society for Serotonin Research

Feb 27, 2023, 6:50 AM EST - 3 years ago

Bright Minds Biosciences Provides Clinical Program Updates and Outlines Anticipated Milestones for 2023

Feb 17, 2023, 6:50 AM EST - 3 years ago

Bright Minds Biosciences Announces Non-Executive Director Appointment

Feb 8, 2023, 4:05 PM EST - 3 years ago

Bright Minds Biosciences Announces Receipt of Nasdaq Deficiency Letter Regarding Independent Director and Audit Committee Requirements

Jan 27, 2023, 4:05 PM EST - 3 years ago

Bright Minds Biosciences Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Jan 9, 2023, 4:05 PM EST - 3 years ago

Bright Minds Biosciences Announces Resignation of Board Member

Dec 2, 2022, 7:07 PM EST - 3 years ago

Bright Minds Biosciences Announces Closing of Non-Brokered Private Placement

Nov 28, 2022, 6:50 AM EST - 3 years ago

Bright Minds Biosciences Announces Non-Brokered Private Placement

Nov 23, 2022, 11:35 AM EST - 3 years ago

Bright Minds Biosciences Appoints Drug Development Executive Mark A. Smith M.D.

Sep 7, 2022, 6:50 AM EDT - 4 years ago

Bright Minds Biosciences Announces Appointment of Doug Williamson to Board of Directors

Aug 31, 2022, 6:50 AM EDT - 4 years ago

Bright Minds Biosciences Initiates Dosing in Phase I Clinical Trial of BMB-101 for Dravet Syndrome

Aug 30, 2022, 3:35 PM EDT - 4 years ago

Bright Minds Biosciences Announces Closing of $4 Million Unit Offering

Aug 23, 2022, 9:07 PM EDT - 4 years ago

Bright Minds Announces Pricing of Overnight Marketed Offering of Units

Aug 22, 2022, 7:05 PM EDT - 4 years ago

Bright Minds Announces Overnight Marketed Offering of Units

Aug 18, 2022, 3:34 PM EDT - 4 years ago

Bright Minds Biosciences Comments on Recent Trading Activity

Jun 27, 2022, 6:50 AM EDT - 4 years ago

Bright Minds Biosciences Announces Changes to its Executive Leadership Team, Marking the Transition to a Development Organization

May 12, 2022, 6:50 AM EDT - 4 years ago

Bright Minds Biosciences to Host Key Opinion Leader Symposium on Dravet Syndrome

May 2, 2022, 6:50 AM EDT - 4 years ago

Bright Minds Biosciences Establishes Scientific Advisory Board, Comprising Five Preeminent Physicians and Scientists Across Mental Health Specialties

Apr 19, 2022, 6:50 AM EDT - 4 years ago

Bright Minds Biosciences to Host Symposium on Therapeutic Developments within Dravet Syndrome and Featuring a Panel with Key Opinion Leaders

Mar 14, 2022, 6:50 AM EDT - 4 years ago

Bright Minds Biosciences Announces Successful Completion of 28-Day Toxicology Studies and Advancement to First-in-Human Clinical Trial

Mar 8, 2022, 7:30 AM EST - 4 years ago

Bright Minds Biosciences to Present at the Oppenheimer 32nd Annual Healthcare Conference

Alchemisttt Jun. 4 at 4:19 PM

$VERU this is gonna $DRUG

0 · Reply

Trick2MoneyisHavingSum Jun. 3 at 12:27 PM

$HUBC when you see it squeezing JUMP in FOLKS $DRUG $NUKK

0 · Reply

Source206 Jun. 2 at 5:41 PM

$DRUG I'm buying at these prices

0 · Reply

Benbobaggins Jun. 1 at 11:25 AM

$SOAR anyone remember when $DRUG flew. Pretty sure $SOAR can soar through🐋🐳🐂🚀

0 · Reply

Trick2MoneyisHavingSum May. 28 at 11:00 AM

$ATPC fireworks after $6.72 $DRUG $WHLR

0 · Reply

Paraboljoker May. 27 at 2:06 PM

$ISPC has that broken look above $4.30 key break , who remembers $DRUG ??

0 · Reply

Paraboljoker May. 27 at 12:02 PM

$ISPC has that broken look above $4.10, who remembers $DRUG?

0 · Reply

TraderBuckNKY May. 27 at 11:42 AM

1 · Reply

LeiteCondensado May. 27 at 10:20 AM

$SNGX - Imagine if this did a $DRUG type of move?

0 · Reply

simplifocused May. 23 at 1:15 PM

$ARTL this is the next $DRUG NFA

0 · Reply

Trick2MoneyisHavingSum May. 22 at 6:35 PM

$AKTX come PEOPLE come $WOK $DRUG

0 · Reply

CoffeeRocks May. 21 at 6:33 PM

$CMND $DRUG $IBOGF $OPTI.CSE Opti mum

2 · Reply

Trick2MoneyisHavingSum May. 21 at 4:21 PM

$ATPC if it breaks $4 then I'm scared of what could happen $NUKK $DRUG

0 · Reply

Lowkeyoptions May. 21 at 3:04 PM

$GH $RGC $DRUG $GSK $MRNA Blood cancer diagnosis is a big market and a big deal imo The cancer testing company said Guardant360 Liquid CDx is now the largest FDA-approved liquid biopsy panel and evaluates a genomic footprint that is 100 times wider than the earlier Guardant360 CDx test. The test combines genomic and epigenomic insights from a single blood sample to help clinicians make more informed treatment decisions

0 · Reply

stoxx0007 May. 20 at 7:46 PM

$DRUG = DRUG will probably close UP 10% today.

0 · Reply

GIG888888888 May. 20 at 5:28 PM

$DRUG what is the implied move?

0 · Reply

DonVigo May. 20 at 2:48 PM

$SLS $CAR or $DRUG squeeze in play. POWER ON!

0 · Reply

Quantumup May. 20 at 11:34 AM

Piper Sandler⬆️ $DRUG's PT to $220, reit'd at Overweight/said—We caught up with DRUG following earnings, where mgmt reflected confidence in the progress made across programs this past quarter. SLNO - NBIX HRMY $RYTM LBPH - HLUBF / HLBBF PFE UCBJY STOK - BIIB JAZZ $PRAX XENE OVID Here's what else Piper Sandler had to say: https://x.com/Quantumup1/status/2057061836768329992?s=20

0 · Reply

tbh2013 May. 20 at 12:01 AM

$DRUG $GNS out of how many stocks has a chance to make that move? Not going to happen on this 💩

0 · Reply

lordbealish May. 19 at 11:39 PM

$DRUG ibkr indicate earning today after hour !!!! when ?

0 · Reply

hugoraciel May. 19 at 11:09 PM

$GNS ive seen stocks go from .10 cents to over $150 in 48hrs I hope this is the case w this one $DRUG

1 · Reply

CoffeeRocks May. 19 at 11:51 AM

$TCNNF $TLRY $TNXP $DRUG https://www.marijuanamoment.net/army-reminds-soldiers-of-zero-tolerance-marijuana-policy-warning-that-even-cbd-lotion-remains-banned/

1 · Reply

Market Cap	724.27M
Revenue (ttm)	0.00
Net Income (ttm)	-8.74M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	825,000
Avg Vol	236,622
Day's Range	N/A - N/A
Shares Out	9.73M
Stochastic %K	9%
Beta	-5.53
Analysts	Strong Sell
Price Target	$156.60